Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aeterna Zentaris Inc T.AEZS

Alternate Symbol(s):  AEZS

Healthcare Biotechnology
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The... see more

Recent & Breaking News (TSX:AEZS)

Pete’s Picks: Lukas Lundin’s (V.FST) big gold bet, and other Stockhouse stories

Peter Kennedy November 7, 2014

SHAREHOLDER ALERT: Investigation on Behalf of Aeterna Zentaris, Inc. Investors Announced by Law Offices of Howard G. Smith

Business Wire November 7, 2014

Law firm launches investigation into Aeterna Zentaris (T.AEZ) over NDA failure

Stockhouse Editorial November 7, 2014

The Rosen Law Firm Announces Investigation of Securities Claims Against Aeterna Zentaris, Inc.

Business Wire November 6, 2014

Microcap Report: Aeterna Zentaris (T.AEZ), Orbite Auminae (T.ORT) active

Stockhouse Editorial November 6, 2014

eResearch Posts Channel Breakers and Trendline Breaks for Wednesday, November 5

Accesswire November 6, 2014

Aeterna Zentaris (T.AEZ) dumps 46% as U.S. FDA denies Macrilen(TM) NDA

Gaalen Engen November 6, 2014

IIROC Trade Resumption - AEZ

Canada NewsWire November 6, 2014

IIROC Trade Resumption - Aeterna Zentaris Inc.

Newsfile November 6, 2014

FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen(TM) NDA in Adult Growth Hormone Deficiency

PR Newswire November 6, 2014

FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen(TM) NDA in Adult Growth Hormone Deficiency

Canada NewsWire November 6, 2014

IIROC Trade Halt - Aeterna Zentaris Inc.

Newsfile November 5, 2014

Aeterna Zentaris Reports Third Quarter 2014 Financial and Operating Results

Canada NewsWire November 4, 2014

Aeterna Zentaris to Announce Third Quarter 2014 Financial and Operating Results on November 4, 2014

PR Newswire October 28, 2014

Aeterna Zentaris (T.AEZ) launches full-time US sales force for ASCEND's EstroGel(R)

Stockhouse Editorial October 27, 2014

Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's EstroGel®

Canada NewsWire October 27, 2014

Aeterna Zentaris Appoints Phil Theodore as Chief Administrative Officer, General Counsel and Corporate Secretary

Canada NewsWire October 7, 2014

Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York

Canada NewsWire September 2, 2014

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014

Business Wire August 11, 2014

Aeterna Zentaris Reports Second Quarter 2014 Financial and Operating Results

Canada NewsWire August 7, 2014